FDA Bans Food Additive Found in Sports Drinks, Sodas

Follow Drugslib on

Medically reviewed by Drugs.com.

By Robin Foster HealthDay Reporter

WEDNESDAY, July 3, 2024 -- A regulation allowing the use of brominated vegetable oil in food was revoked Tuesday by the U.S. Food and Drug Administration after the agency concluded the additive was unsafe for human consumption.

Brominated vegetable oil (BVO) contains bromine, which is found in fire retardants. Small quantities of BVO have been used legally in some citrus-flavored drinks in the United States to keep the flavor evenly distributed, the FDA explained in a news release announcing the ban, which takes effect Aug. 2.

The agency first proposed the ban in November. But BVO was banned in the U.K. in 1970, followed by India in 1990, the E.U. in 2008 and Japan in 2010, according to the Center for Science in the Public Interest.

In 1970, the FDA concluded that its use in food was not generally recognized as safe because of toxicity concerns. Following that decision, the agency began regulating BVO as a food additive while also conducting safety studies, Reuters reported. The results of that research prompted the ban.

Some experts said the ban was long overdue.

“The FDA’s decision to ban brominated vegetable oil [BVO] in food is a victory for public health. But it’s disgraceful that it took decades of regulatory inaction to protect consumers from this dangerous chemical,” Scott Faber, senior vice president of government affairs at the Environmental Working Group, said in a statement.

“It's outrageous that for years Americans have been consuming a chemical banned in Europe and Japan. The FDA’s belated action on BVO underscores the urgent need for more rigorous and timely oversight of food additives,” Faber added.

Many beverage makers have already replaced BVO with an alternative ingredient, according to the FDA. “Few beverages in the U.S. contain BVO,” it noted.

Sources

  • U.S. Food and Drug Administration, news release, July 2, 2024
  • Environmental Working Group, statement, July 2, 2024
  • Reuters

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-07-03 21:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords